Transcode Therapeutics (RNAZ) Return on Assets (2021 - 2026)
Transcode Therapeutics' (RNAZ) quarterly Return on Assets came in at 0.0% in Q1 2026, up 2.0% YoY from 0.0% in Q1 2025, and up 39.78% on a QoQ basis from 0.0% in Q4 2025.
Transcode Therapeutics (RNAZ) Return on Assets (2021 - 2026) Analysis & Trends
Transcode Therapeutics (RNAZ) has 6 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Assets rose 2.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 2.0% YoY) and the FY2025 annual result came in at 0.0%, up 2.0% from the prior year.
- Return on Assets improved to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2026 to a low of 0.04% in Q3 2025.
- A 5-year average of 0.02% and a median of 0.03% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2023 — Return on Assets fell 3 bps — and 2025, when it gained 2 bps.
- Tracing RNAZ's Return on Assets over 5 years: stood at 0.02% in 2022, then retreated by 24 bps to 0.03% in 2023, then slipped by 10 bps to 0.03% in 2024, then surged by 84 bps to 0.0% in 2025, then soared by 40 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Transcode Therapeutics | 2.84 Mn | 2.84 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.04% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |